FI954257A7 - Bisyklisen oksatsolin ja tiatsolin substituoituja eettereitä - Google Patents

Bisyklisen oksatsolin ja tiatsolin substituoituja eettereitä Download PDF

Info

Publication number
FI954257A7
FI954257A7 FI954257A FI954257A FI954257A7 FI 954257 A7 FI954257 A7 FI 954257A7 FI 954257 A FI954257 A FI 954257A FI 954257 A FI954257 A FI 954257A FI 954257 A7 FI954257 A7 FI 954257A7
Authority
FI
Finland
Prior art keywords
thiazole
substituted ethers
oxazole
bicyclic
bicyclic oxazole
Prior art date
Application number
FI954257A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI954257A0 (fi
Inventor
Thomas D Aicher
Seung Hoon Cheon
Jeffrey Nadelson
William Ronald James Simpson
William Joseph Houlihan
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI954257A0 publication Critical patent/FI954257A0/fi
Publication of FI954257A7 publication Critical patent/FI954257A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI954257A 1994-09-13 1995-09-11 Bisyklisen oksatsolin ja tiatsolin substituoituja eettereitä FI954257A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30524994A 1994-09-13 1994-09-13

Publications (2)

Publication Number Publication Date
FI954257A0 FI954257A0 (fi) 1995-09-11
FI954257A7 true FI954257A7 (fi) 1996-03-14

Family

ID=23180015

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954257A FI954257A7 (fi) 1994-09-13 1995-09-11 Bisyklisen oksatsolin ja tiatsolin substituoituja eettereitä

Country Status (26)

Country Link
EP (1) EP0702015B1 (da)
JP (1) JPH08109183A (da)
KR (1) KR960010649A (da)
CN (1) CN1130186A (da)
AT (1) ATE158585T1 (da)
AU (1) AU3055295A (da)
BR (1) BR9504004A (da)
CA (1) CA2157950A1 (da)
CO (1) CO4410332A1 (da)
CZ (1) CZ229595A3 (da)
DE (1) DE69500758T2 (da)
DK (1) DK0702015T3 (da)
ES (1) ES2108550T3 (da)
FI (1) FI954257A7 (da)
GR (1) GR3025405T3 (da)
HU (1) HUT73432A (da)
IL (1) IL115235A0 (da)
MY (1) MY132008A (da)
NO (1) NO953569L (da)
NZ (1) NZ272976A (da)
PE (1) PE50296A1 (da)
PL (1) PL310372A1 (da)
SI (1) SI0702015T1 (da)
SK (1) SK111195A3 (da)
TR (1) TR199501115A2 (da)
ZA (1) ZA957699B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699866B2 (en) 2001-04-17 2004-03-02 Sepracor Inc. Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof
DE10333935A1 (de) * 2003-07-25 2005-02-24 Aventis Pharma Deutschland Gmbh Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
FR2858321B1 (fr) * 2003-07-28 2006-01-20 Servier Lab Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1249992A (en) * 1983-11-10 1989-02-14 Marcel Muller Oxazolidines
ATE185564T1 (de) * 1992-08-31 1999-10-15 Sankyo Co Oxazolidin-derivate mit antidiabetika und anti- fettleibigkeit-eigenschaften, ihre herstellung und therapeutische verwendung
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
US5521202A (en) * 1993-04-07 1996-05-28 Taiho Pharmaceutical Co., Ltd. Thiazolidine derivatives and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
CO4410332A1 (es) 1997-01-09
JPH08109183A (ja) 1996-04-30
MY132008A (en) 2007-09-28
ATE158585T1 (de) 1997-10-15
DK0702015T3 (da) 1998-01-12
IL115235A0 (en) 1995-12-31
PE50296A1 (es) 1996-12-05
PL310372A1 (en) 1996-03-18
TR199501115A2 (tr) 1996-06-21
KR960010649A (ko) 1996-04-20
GR3025405T3 (en) 1998-02-27
DE69500758T2 (de) 1998-02-26
EP0702015A1 (en) 1996-03-20
ES2108550T3 (es) 1997-12-16
DE69500758D1 (de) 1997-10-30
CN1130186A (zh) 1996-09-04
SI0702015T1 (en) 1998-02-28
NO953569D0 (no) 1995-09-11
CZ229595A3 (en) 1996-04-17
CA2157950A1 (en) 1996-03-14
NZ272976A (en) 1996-09-25
ZA957699B (en) 1997-03-13
SK111195A3 (en) 1997-06-04
AU3055295A (en) 1996-03-28
BR9504004A (pt) 1996-09-24
EP0702015B1 (en) 1997-09-24
FI954257A0 (fi) 1995-09-11
HU9502663D0 (en) 1995-11-28
HUT73432A (en) 1996-07-29
NO953569L (no) 1996-03-14

Similar Documents

Publication Publication Date Title
FI963238A7 (fi) Heteroaromaattisia oksatsoli yhdisteitä ja niiden käyttö
EE200100074A (et) Asendatud oksasoolide ja tiasoolide derivaadid kui hPPARy ja hPPARa aktivaatorid
FI955051A0 (fi) Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö
MX9200273A (es) Nuevos compuestos de sulfonilureas y procedimientopara su obtencion
FI953666L (fi) Hetersykliset yhdisteet ja niiden valmistus ja käyttö
FI943749L (fi) Taksaanijohdannaisten fosfono-oksimetyylieetterit
FI954131L (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
BR9503740A (pt) Composiçao estabilizada contra os efeitos nocivos de radiaçao actínica
FI930747A7 (fi) Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö
FI954130A7 (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
FI930746A7 (fi) Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö
FI943313L (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
FI961184L (fi) Menetelmä norborneenin ja substituoitujen norborneenijohdannaisten valmistamiseksi
FI950406A7 (fi) Titaanipitoisten materiaalien käsittely
FI905748A7 (fi) Menetelmä dopamiinin ja dopamiinijohdannaisten 4-O-fosfaattien valmis tamiseksi
FI960813A7 (fi) Menetelmä alkyylieetterien ja niiden seosten valmistamiseksi
FI956256A7 (fi) Menetelmä alkyylieetterien ja niiden seosten valmistamiseksi
NO952568D0 (no) Behandling av cellulosemateriale og blandinger for anvendelse for dette
ITTO930606A1 (it) Composizione di intonaco per interni e procedimento per la sua fabbricazione.
FI954257A7 (fi) Bisyklisen oksatsolin ja tiatsolin substituoituja eettereitä
FI963130L (fi) Heterosykliset yhdisteet sekä niiden valmistus ja käyttö
FI911644A7 (fi) Terapeuttinen yhdiste ja koostumus
FI955719A7 (fi) Selluloosamateriaalien käsittely
FI923744A7 (fi) Menetelmä ja välituotteita 6-fluoribentsisotiatsolien valmistamiseksi
SG33491A1 (en) Bicyclic oxazole and thiazole substituted ethers

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FD Application lapsed